An Introduction to Devices
With improvements in technology and material science, devices are becoming an important component of the treatment paradigm for many cardiovascular conditions. Pacemakers are an established treatment option for patients with irregular heart rhythm. Increasing functionality such as MRI-safety, leadless options and automation have impacted patient experiences and outcomes. Stent technology is continuously evolving, with bioabsorbable-polymer drug-eluting stents and biodegradable stents being some of the most recent advances.
Browse the content below where leading experts discuss the latest data in video interviews and short articles from our conference hub, and browse the selection of peer-reviewed articles from our journal portfolio.
Our supporting partners do not constitute an endorsement of the content on this page.
Latest Advances in Transcatheter Mitral Valve Replacement
Heart International. 2021;15(2):79–83
Transcatheter-based therapies have become central to the treatment of valvular heart disease, particularly aortic stenosis.1–5 The first transcatheter aortic valve replacement (TAVR) was performed in 2002 and, in two short decades, TAVR has become a mainstay for the treatment of aortic stenosis for all surgical risk categories.1,6–8 With the global success and adoption of TAVR, significant efforts […]
An Update on Drug-eluting Technology in Peripheral Arteries to Treat Peripheral Arterial Disease
Heart International. 2021;15(2):73–8
Drug-eluting technology is a widely accepted, proven treatment for coronary artery stenosis and occlusions, with superior results when compared with bare metal stents or plain old balloon angioplasty (POBA).1,2 Many studies also proved drug-eluting stents (DES) and drug-coated balloons (DCB) to be superior to POBA when treating lower limb arteries.3,4 Paclitaxel is a cytostatic chemotherapy drug […]
An Unusual Cause of Pacemaker Lead Displacement: ‘Reverse Ratchet’ Syndrome
Heart International. 2021;15(2):103–5
Lead displacement in pacemakers is a common implantation-related procedural complication, often resulting in prolonged hospital stays for patients and increased healthcare costs.1,2 The frequency of long-term lead displacement ranges between 1.8% and 8.0%.3,4 Recognizing lead displacement complications is an essential part of caring for patients with these cardiac devices.1 Case report An 89-year-old man underwent implantation of […]
The ACURATE neo™ and neo2™ Valve Systems
Heart International. 2021;15(1):37-41 DOI: https://doi.org/10.17925/HI.2021.15.1.37
Transcatheter aortic valve replacement (TAVR) has seen worldwide explosive growth. The current USA guidelines no longer use risk in choosing between TAVR and surgical aortic valve replacement, and the European guidelines have extended the recommendation for TAVR to lower risk groups.1,2 This rapid expansion has been driven by data from randomized trials showing TAVR as […]
Haran Burri, EHRA 2021: The Future of Pacing
Prof. Haran Burri (Lead Cardiac Physiologist, University of Oxford, Oxford, UK) gave us an update on the future of pacing from the European Heart Rhythm Association (EHRA) Virtual Meeting 2021. Questions: What is the potential role of conduction system pacing as an alternative to biventricular pacing? (0.21) What have we learned from early clinical experience […]
HRS 2020 Highlights: Does Consultation with an Electrophysiologist Impact Disparities in Implantable Cardioverter Defibrillator Use by Sex and Race?
Clinical trial results show stark disparities in use of life-saving implantable cardiverter defibrillator (ICD) interventions based on sex and race, suggesting potential bias in care pathways to electrophysiologists (EP). Dr Anne B Curtis discusses her recent study presented at HRS 2020 in an expert interview. Q. What were the aims and design of your recent […]
New Consumer Guidance on Wearable Devices from the Consumer Electronics Show 2020
Heart International. 2020;14(1):9-10 DOI: https://doi.org/10.17925/HI.2020.14.1.9
The current landscape of wearable technology is one of the most exciting and rapidly changing fields in medicine, especially for the general consumer.1 The potential of capturing a wider and deeper range of personal health information is vast, allowing for changes in care to a more personalised approach across all therapy areas. Cardiology, in particular, […]
Quantification of Seasonal Variation in Daily Physical Activity in Individuals with Heart Failure and Implantable Cardioverter Defibrillator/Cardiac Resynchronisation Therapy Devices
Heart International. 2019;13(2):31–7 DOI: https://doi.org/10.17925/HI.2019.13.2.31
In individuals with heart failure (HF) who also have implanted cardioverter defibrillators and/or cardiac resynchronisation therapy (ICD/CRT) devices, low daily physical activity (PA) levels lead to increased risk of mortality, poor aerobic capacity and lower health-related quality of life.1 Improving daily PA in these individuals may, therefore, be an important clinical endpoint; however, designing interventional […]
HRC 2019 – Arrhythmia Alliance Symposia: Controversies
Coverage of the Arrhythmia Alliance Symposia – Controversies presented at HRC 2019 and chaired by Drs Vanita Arora and Vias Markides. Filmed at the Heart Rhythm Congress (HRC) 2019 in Birmingham, UK, October 2019 in partnership with Arrhythmia Alliance.
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!